Quality of life as a primary end point in oncology

Annals of Oncology

Volumn 12, Issue SUPPL. 3, 2001, Pages

  Roila, Fausto ^a   Cortesi, Enrico ^b  

^a Policlinico Hospital   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Clinical benefit; Quality of life; Research end point

Indexed keywords

ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER RESEARCH; CANCER SURVIVAL; CANCER THERAPY; CLINICAL TRIAL; EVALUATION; HUMAN; MEDICAL ASSESSMENT; MEDICAL INFORMATION; MEDICAL LITERATURE; ONCOLOGY; OUTCOMES RESEARCH; PHYSICIAN; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; TREATMENT PLANNING; TUMOR CLASSIFICATION;

EID: 0035664471     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/12.suppl_3.s3     Document Type: Article

References (11)

1. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines
2. Measuring health-related quality of life
3. Endpoints in cancer clinical trials: Is there a need for measuring quality of life?
4. Quality of life assessment and clinical decision-making
5. Quality-of-life measures as providers of information on value-for-money of health interventions
6. Improving the quality of life during chemotherapy for advanced breast cancer
7. Prognostic implications of quality of life
8. A phase II trial of gemcitabine in patients with 5FU-refractory pancreas cancer
9. Improvements in survival and clinical benefit with gemcitabine as first line therapy for patients with advanced pancreatic cancer: A randomized trial
10. Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatica hormone-resistant prostate cancer: A Canadian randomized trial with palliative end points
11. Clinical benefit as a primary efficacy endpoint